cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Zymeworks Inc
10 own
15 watching
Current Price
$8.25
$-0.17
(-2.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
508.98M
52-Week High
52-Week High
10.8
52-Week Low
52-Week Low
4.11
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization508.98M
icon52-Week High10.8
icon52-Week Low4.11
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio--
What does the Zymeworks Inc do?
N/A
Read More
How much money does Zymeworks Inc make?
News & Events about Zymeworks Inc.
Globe Newswire
29days ago
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Bank of America ...
Business Wire
1month ago
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will report its first quarter 2023 financial results after market close on May 8, 2023. Following the announcement, management will host a...
Business Wire
1month ago
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced the appointment of Derek J. Miller to its board of directors effective April 10, 2023. Mr. Miller brings extensive commercial, corporate and business development...
Benzinga
2 months ago
Latest Ratings for ZYME DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Dec 2021Raymond JamesDowngradesStrong BuyOutperform Dec 2021SVB LeerinkUpgradesMarket PerformOutperform View More Analyst Ratings for ZYME View the Latest Analyst Ratings read more...
Business Wire
3 months ago
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Barclays Global Healthcare Conference. Zymeworks management will participate in...
Frequently Asked Questions
Frequently Asked Questions
What is Zymeworks Inc share price today?
plus_minus_icon
Can Indians buy Zymeworks Inc shares?
plus_minus_icon
How can I buy Zymeworks Inc shares from India?
plus_minus_icon
Can Fractional shares of Zymeworks Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Zymeworks Inc stocks?
plus_minus_icon
What is today’s traded volume of Zymeworks Inc?
plus_minus_icon
What is today’s market capitalisation of Zymeworks Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Zymeworks Inc?
plus_minus_icon
What percentage is Zymeworks Inc down from its 52-Week High?
plus_minus_icon
What percentage is Zymeworks Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.25
$-0.17
(-2.02%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00